Knowledge, Attitude and Practice Toward Intracerebral Hemorrhage Prevention Among Patients Taking Oral Anticoagulants

Wei Xiao1, Yanqiong Liu2, Hua Tang3

  • 1Department of Neurosurgical Care Unit, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415003, People's Republic of China.

Insights

Patients on oral anticoagulation (OAC) have poor knowledge and attitudes towards preventing intracerebral hemorrhage (ICH). Their practice is influenced by age, medication, and attitude, not knowledge.

Area of Science:

  • Medical research
  • Clinical practice
  • Patient safety

Background:

  • Intracerebral hemorrhage (ICH) affects up to 1% of oral anticoagulation (OAC) users annually.
  • Understanding patient knowledge, attitude, and practice (KAP) is crucial for ICH prevention in OAC users.

Purpose of the Study:

  • To explore the knowledge, attitude, and practice (KAP) regarding ICH prevention among patients using OACs.
  • To analyze the relationships between KAP and demographic/medication factors.

Main Methods:

  • A multicenter cross-sectional survey involving 536 OAC patients.
  • Self-administered questionnaires assessed KAP towards ICH prevention.
  • Structural equation modeling analyzed KAP relationships.

Main Results:

  • Average KAP scores indicated insufficient knowledge and negative attitudes, but proactive practice.
  • Rivaroxaban users had lower knowledge but higher attitude/practice scores than Warfarin/Dabigatran users.
  • Attitude positively impacted practice; knowledge negatively impacted attitude and practice.

Conclusions:

  • OAC patients demonstrate inadequate knowledge and attitudes concerning ICH prevention.
  • Practice scores are influenced by age, OAC type, and attitude, underscoring the need for targeted interventions.
Abstract

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
663
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
795
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
507
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.1K